Enhancing Proton Radiosensitivity of Chondrosarcoma Using Nanoparticle-Based Drug Delivery Approaches: A Comparative Study of High- and Low-Energy Protons
International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11481
DOI: 10.3390/ijms252111481 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Mihaela Tudor und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Physics, Horia Hulubei National Institute of Physics and Nuclear Engineering, Reactorului 30, P.O. Box MG-6, 077…. Hauptthemen laut MEDLINE: Chondrosarcoma, Doxorubicin, Protons, Cell Survival. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Education and Research, “Nucleu” Programe within the National Plan for Research, Development and Innovation 2022–2027, European Regional Development Fund.
Abstract (Originalsprache)
To overcome chondrosarcoma’s (CHS) high chemo- and radioresistance, we used polyethylene glycol-encapsulated iron oxide nanoparticles (IONPs) for the controlled delivery of the chemotherapeutic doxorubicin (IONPDOX) to amplify the cytotoxicity of proton radiation therapy. Human 2D CHS SW1353 cells were treated with protons (linear energy transfer (LET): 1.6 and 12.6 keV/µm) with and without IONPDOX. Cell survival was assayed using a clonogenic test, and genotoxicity was tested through the formation of micronuclei (MN) and γH2AX foci, respectively. Morphology together with spectral fingerprints of nuclei were measured using enhanced dark-field microscopy (EDFM) assembled with a hyperspectral imaging (HI) module and an axial scanning fluorescence module, as well as scanning electron microscopy (SEM) coupled with energy-dispersive X-Ray spectroscopy (EDX). Cell survival was also determined in 3D SW3153 spheroids following treatment with low-LET protons with/without the IONPDOX compound. IONPDOX increased radiosensitivity following proton irradiation at both LETs in correlation with DNA damage expressed as MN or γH2AX. The IONPDOX–low-LET proton combination caused a more lethal effect compared to IONPDOX–high-LET protons. CHS cell biological alterations were reflected by the modifications in the hyperspectral images and spectral profiles, emphasizing new possible spectroscopic markers of cancer therapy effects. Our findings show that the proposed treatment combination has the potential to improve the management of CHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life and Environmental Physics, Horia Hulubei National Institute of Physics and Nuclear Engineering, Reactorului 30, P.O. Box MG-6, 077125 Magurele, Romania.
- Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095 Bucharest, Romania.
- Department of Bioengineering and Biotechnology, Faculty of Medical Engineering, National University for Science and Technology Politehnica of Bucharest, Gheorghe Polizu Street, 1-7, 011061 Bucharest, Romania.
- Applied Sciences Doctoral School, National University for Science and Technology Politehnica of Bucharest, 060042 Bucharest, Romania.
- Laboratory of Nuclear Problems, Joint Institute for Nuclear Research, 6 Joliot-Curie Street, 141980 Dubna, Moscow Region, Russia.
- Doctoral School of Computer Sciences, National University for Science and Technology Politehnica of Bucharest, 060042 Bucharest, Romania.
ORCID-Profile: Nicolae Tarba, Liviu Craciun, Mihai Radu, Mona Mihailescu, Diana Iulia Savu
Förderung
- Romanian Ministry of Education and Research
- “Nucleu” Programe within the National Plan for Research, Development and Innovation 2022–2027
- European Regional Development Fund
- Center for Innovative Manufacturing Solutions of Smart Biomaterials and Biomedical Surfaces–INOVABIOMED
Zitieren
APA
Tudor, M., Popescu, R. C., Irimescu, I. N., Rzyanina, A., Tarba, N., Dinischiotu, A., Craciun, L., Esanu, T. R., Vasile, E., Hotnog, A. T., Radu, M., Mytsin, G., Mihailescu, M., & Savu, D. I. (2024). Enhancing Proton Radiosensitivity of Chondrosarcoma Using Nanoparticle-Based Drug Delivery Approaches: A Comparative Study of High- and Low-Energy Protons. International Journal of Molecular Sciences, 25(21), 11481. https://doi.org/10.3390/ijms252111481
Vancouver
Tudor M, Popescu RC, Irimescu IN, Rzyanina A, Tarba N, Dinischiotu A, et al. Enhancing Proton Radiosensitivity of Chondrosarcoma Using Nanoparticle-Based Drug Delivery Approaches: A Comparative Study of High- and Low-Energy Protons. International Journal of Molecular Sciences. 2024;25(21):11481. doi:10.3390/ijms252111481
BibTeX
@article{Tudor2024,
author = {Tudor, Mihaela and Popescu, Roxana Cristina and Irimescu, Ionela N and Rzyanina, Ann and Tarba, Nicolae and Dinischiotu, Anca and Craciun, Liviu and Esanu, Tiberiu Relu and Vasile, Eugeniu and Hotnog, Andrei Theodor and Radu, Mihai and Mytsin, Gennady and Mihailescu, Mona and Savu, Diana Iulia},
title = {Enhancing Proton Radiosensitivity of Chondrosarcoma Using Nanoparticle-Based Drug Delivery Approaches: A Comparative Study of High- and Low-Energy Protons},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11481},
doi = {10.3390/ijms252111481}
}
EUVIMED